Cargando…
The Reproducibility of Histopathologic Assessments of Programmed Cell Death-Ligand 1 Using Companion Diagnostics in NSCLC
INTRODUCTION: Accurate results on the status of programmed cell death-ligand 1 (PD-L1) rely on not only the quality of immunohistochemistry testing but also the accuracy of the pathologic assessments. We explored the intraobserver and interobserver reproducibility of the interpretations for the comp...
Autores principales: | Yuan, Pei, Guo, Changyuan, Li, Lin, Guo, Lei, Zhang, Fanshuang, Ying, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474465/ https://www.ncbi.nlm.nih.gov/pubmed/34589980 http://dx.doi.org/10.1016/j.jtocrr.2020.100102 |
Ejemplares similares
-
Variation of Programmed Death Ligand 1 Expression After Platinum-based Neoadjuvant Chemotherapy in Lung Cancer
por: Guo, Lei, et al.
Publicado: (2019) -
Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
por: Jørgensen, Jan Trøst, et al.
Publicado: (2022) -
High MAF of EGFR mutations and high ratio of T790M sensitizing mutations in ctDNA predict better third‐generation TKI outcomes
por: Li, Yan, et al.
Publicado: (2020) -
Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients: A retrospective analysis
por: Lei, Huizi, et al.
Publicado: (2023) -
The correlation between programmed death-ligand 1 expression and driver gene mutations in NSCLC
por: Yang, Haitao, et al.
Publicado: (2017)